Clinical spectrum, pathogenesis and treatment of linear IgA bullous dermatosis

Journal of Dermatology

Volumn 28, Issue 11, 2001, Pages 651-653

  Zone, J J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DAPSONE; IMMUNOSUPPRESSIVE AGENT;

ANTIGEN SPECIFICITY; BULLOUS SKIN DISEASE; CLINICAL FEATURE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOLOGY; LEUKOPENIA; LIVER FUNCTION TEST; METHEMOGLOBINEMIA; PATHOGENESIS; SHORT SURVEY;

EID: 0035199131     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2001.tb00056.x     Document Type: Short Survey

References (12)

1. Linear IgA dermatosis of childhood (chronic bullous disease of childhood)
2. The pathogenesis of dermatitis herpetiformis
3. Linear IgA disease in adults
4. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis
5. Type VII collagen is the antigen recognized by IgA anti-sub lamina densa autoantibodies
6. Antigenic specificity of antibodies from patients with linear basement membrane deposition of IgA
7. IgA antibodies in chronic bullous disease of childhood react with a 97 kDa basement membrane zone protein
8. Immunoblotting studies of linear IgA disease
9. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells
10. The 97kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2
11. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180
12. Inhibition of neutrophil adherence to antibody by dapsone: A possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses